Search research articles
Contact Us
Filters
Showing results (101-110 of 362) with videos related to
Page
of 37
Sort By:
Alimentary Pharmacology & Therapeutics
|
May 23, 2012
Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines
U Kopylov, A Levin, E Mendelson, et al.
United European Gastroenterology Journal
|
December 30, 2024
Gastrointestinal Perforations Associated With JAK Inhibitors: A Disproportionality Analysis of the FDA Adverse Event Reporting System
Adam Goldman, Emanuel Raschi, Amit Druyan, et al.
World Journal of Gastrointestinal Pathophysiology
|
April 19, 2013
Cytomegalovirus positive ulcerative colitis: A single center experience and literature review
Uri Kopylov, Gila Sasson, Bella Geyshis, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 22, 2026
Curcumin-QingDai combination for active ulcerative colitis: A cost-effectiveness analysis
Henit Yanai, David Choi, Shomron Ben-Horin, et al.
Clinical and Experimental Immunology
|
March 22, 2008
Lidocaine down-regulates nuclear factor-kappaB signalling and inhibits cytokine production and T cell proliferation
A Lahat, S Ben-Horin, S B Horin, et al.
Case Reports in Gastroenterology
|
May 7, 2025
Vancomycin Therapy for Induction and Maintenance of Remission in a Patient with Refractory Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report and Literature Review
Naama Lang, Yana Davidov, Tomer Hoffman, et al.
Crohn'S & Colitis 360
|
March 25, 2026
Pharmacokinetics and efficacy of subcutaneous infliximab 120 mg every 2 weeks: a post hoc comparison with intravenous dosing in a phase 1 study in patients with inflammatory bowel disease
Stefan Schreiber, Byong Duk Ye, Hyunseong Yu, et al.
The American Journal of the Medical Sciences
|
December 16, 2006
Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association
Nurit Tweezer-Zaks, Shomron Ben-Horin, Ginette Schiby, et al.
The Thoracic and Cardiovascular Surgeon
|
April 1, 1987
Cardiac myxomas--surgical experience with a multi-faceted tumor
E Milgalter, H Lotan, L Schuger, et al.
Therapeutic Advances in Gastroenterology
|
November 13, 2025
Mirikizumab in ulcerative colitis: real-world evidence from an international two-center retrospective cohort study
Asaf Levartovsky, Martin Lukáš, Chaya Mushka Abitbol, et al.
Page
of 37
Search research articles
Search
Showing results (101-110 of 362) with videos related to
Sort By:
Page
of 37
Alimentary Pharmacology & Therapeutics
|
May 23, 2012
Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines
U Kopylov, A Levin, E Mendelson, et al.
United European Gastroenterology Journal
|
December 30, 2024
Gastrointestinal Perforations Associated With JAK Inhibitors: A Disproportionality Analysis of the FDA Adverse Event Reporting System
Adam Goldman, Emanuel Raschi, Amit Druyan, et al.
World Journal of Gastrointestinal Pathophysiology
|
April 19, 2013
Cytomegalovirus positive ulcerative colitis: A single center experience and literature review
Uri Kopylov, Gila Sasson, Bella Geyshis, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 22, 2026
Curcumin-QingDai combination for active ulcerative colitis: A cost-effectiveness analysis
Henit Yanai, David Choi, Shomron Ben-Horin, et al.
Clinical and Experimental Immunology
|
March 22, 2008
Lidocaine down-regulates nuclear factor-kappaB signalling and inhibits cytokine production and T cell proliferation
A Lahat, S Ben-Horin, S B Horin, et al.
Case Reports in Gastroenterology
|
May 7, 2025
Vancomycin Therapy for Induction and Maintenance of Remission in a Patient with Refractory Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report and Literature Review
Naama Lang, Yana Davidov, Tomer Hoffman, et al.
Crohn'S & Colitis 360
|
March 25, 2026
Pharmacokinetics and efficacy of subcutaneous infliximab 120 mg every 2 weeks: a post hoc comparison with intravenous dosing in a phase 1 study in patients with inflammatory bowel disease
Stefan Schreiber, Byong Duk Ye, Hyunseong Yu, et al.
The American Journal of the Medical Sciences
|
December 16, 2006
Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association
Nurit Tweezer-Zaks, Shomron Ben-Horin, Ginette Schiby, et al.
The Thoracic and Cardiovascular Surgeon
|
April 1, 1987
Cardiac myxomas--surgical experience with a multi-faceted tumor
E Milgalter, H Lotan, L Schuger, et al.
Therapeutic Advances in Gastroenterology
|
November 13, 2025
Mirikizumab in ulcerative colitis: real-world evidence from an international two-center retrospective cohort study
Asaf Levartovsky, Martin Lukáš, Chaya Mushka Abitbol, et al.
Page
of 37